MX2007003923A - Nuevo producto, procedimiento e intermediarios de preparacion de derivados de azetidina. - Google Patents
Nuevo producto, procedimiento e intermediarios de preparacion de derivados de azetidina.Info
- Publication number
- MX2007003923A MX2007003923A MX2007003923A MX2007003923A MX2007003923A MX 2007003923 A MX2007003923 A MX 2007003923A MX 2007003923 A MX2007003923 A MX 2007003923A MX 2007003923 A MX2007003923 A MX 2007003923A MX 2007003923 A MX2007003923 A MX 2007003923A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- intermediates
- azetidine derivatives
- novel product
- methylsulphonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invencion se refiere a un nuevo metodo para la preparacion de derivados de azetidina tal como N-{1-[bis-(4-clorofeniI)metiI] azetidin-3-il)-N-quinol-6-il-metilsulfonamida y el diclorhidrato del mismo y N-{1-[bis-(4-clorofenil)metil]azetidin-3-il}-N- (3,5-dif1uorofeniI)-metilsulfonamida.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0410844A FR2876688B1 (fr) | 2004-10-14 | 2004-10-14 | Nouveau produit, procede et intermediaires de preparation de derives d'azetidine |
PCT/FR2005/002490 WO2006040465A2 (fr) | 2004-10-14 | 2005-10-10 | Nouveau produit, procede et intermediaires de preparation de derives d'azetidine |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007003923A true MX2007003923A (es) | 2007-06-07 |
Family
ID=34954419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007003923A MX2007003923A (es) | 2004-10-14 | 2005-10-10 | Nuevo producto, procedimiento e intermediarios de preparacion de derivados de azetidina. |
Country Status (21)
Country | Link |
---|---|
US (1) | US7687493B2 (es) |
EP (1) | EP1805167A2 (es) |
JP (1) | JP2008516932A (es) |
KR (1) | KR20070063544A (es) |
CN (1) | CN101039931A (es) |
AR (1) | AR051390A1 (es) |
AU (1) | AU2005293454A1 (es) |
BR (1) | BRPI0516507A (es) |
CA (1) | CA2583992A1 (es) |
EA (1) | EA011408B1 (es) |
EC (1) | ECSP077332A (es) |
FR (1) | FR2876688B1 (es) |
IL (1) | IL181904A0 (es) |
MA (1) | MA29513B1 (es) |
MX (1) | MX2007003923A (es) |
NO (1) | NO20072192L (es) |
SG (1) | SG155193A1 (es) |
TN (1) | TNSN07097A1 (es) |
TW (1) | TW200630358A (es) |
WO (1) | WO2006040465A2 (es) |
ZA (1) | ZA200702528B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113045539B (zh) * | 2021-03-30 | 2021-12-07 | 苏州大学 | 2-(4,4-二氯-1-(8-喹啉基)-2-氮杂环丁基)羧酸酯衍生物的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8709887D0 (en) * | 1987-04-27 | 1987-06-03 | Univ Alberta | Alkyl azodicarboxylates |
US5530134A (en) * | 1994-09-06 | 1996-06-25 | Synphar Laboratories Inc. | Synthesis of anabaseine, salts and derivatives thereof |
US6355631B1 (en) * | 2000-03-03 | 2002-03-12 | Aventis Pharma S.A. | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation |
FR2805817B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
BRPI0113146B8 (pt) * | 2000-08-10 | 2021-05-25 | Mitsubishi Pharma Corp | "derivados de prolina e composição farmacêutica que os compreende". |
CN1874991A (zh) * | 2003-08-29 | 2006-12-06 | 小野药品工业株式会社 | 能够结合s1p受体的化合物及其药物用途 |
-
2004
- 2004-10-14 FR FR0410844A patent/FR2876688B1/fr not_active Expired - Fee Related
-
2005
- 2005-10-10 JP JP2007536214A patent/JP2008516932A/ja active Pending
- 2005-10-10 CA CA002583992A patent/CA2583992A1/fr not_active Abandoned
- 2005-10-10 BR BRPI0516507-5A patent/BRPI0516507A/pt not_active IP Right Cessation
- 2005-10-10 MX MX2007003923A patent/MX2007003923A/es active IP Right Grant
- 2005-10-10 EP EP05809232A patent/EP1805167A2/fr not_active Withdrawn
- 2005-10-10 ZA ZA200702528A patent/ZA200702528B/xx unknown
- 2005-10-10 SG SG200905236-6A patent/SG155193A1/en unknown
- 2005-10-10 AU AU2005293454A patent/AU2005293454A1/en not_active Withdrawn
- 2005-10-10 EA EA200700840A patent/EA011408B1/ru not_active IP Right Cessation
- 2005-10-10 WO PCT/FR2005/002490 patent/WO2006040465A2/fr active Application Filing
- 2005-10-10 KR KR1020077008461A patent/KR20070063544A/ko not_active Application Discontinuation
- 2005-10-10 CN CNA2005800350837A patent/CN101039931A/zh active Pending
- 2005-10-13 AR ARP050104296A patent/AR051390A1/es unknown
- 2005-10-13 TW TW094135607A patent/TW200630358A/zh unknown
-
2007
- 2007-03-13 IL IL181904A patent/IL181904A0/en unknown
- 2007-03-16 TN TNP2007000097A patent/TNSN07097A1/fr unknown
- 2007-03-21 EC EC2007007332A patent/ECSP077332A/es unknown
- 2007-03-22 US US11/689,588 patent/US7687493B2/en not_active Expired - Fee Related
- 2007-04-27 NO NO20072192A patent/NO20072192L/no not_active Application Discontinuation
- 2007-05-11 MA MA29896A patent/MA29513B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
EA011408B1 (ru) | 2009-02-27 |
SG155193A1 (en) | 2009-09-30 |
KR20070063544A (ko) | 2007-06-19 |
EA200700840A1 (ru) | 2007-08-31 |
ZA200702528B (en) | 2008-07-30 |
FR2876688A1 (fr) | 2006-04-21 |
AR051390A1 (es) | 2007-01-10 |
MA29513B1 (fr) | 2008-06-02 |
TW200630358A (en) | 2006-09-01 |
ECSP077332A (es) | 2007-04-26 |
TNSN07097A1 (fr) | 2008-06-02 |
AU2005293454A1 (en) | 2006-04-20 |
US20070270463A1 (en) | 2007-11-22 |
WO2006040465A2 (fr) | 2006-04-20 |
IL181904A0 (en) | 2007-07-04 |
CN101039931A (zh) | 2007-09-19 |
BRPI0516507A (pt) | 2008-09-16 |
US7687493B2 (en) | 2010-03-30 |
FR2876688B1 (fr) | 2007-03-16 |
CA2583992A1 (fr) | 2006-04-20 |
JP2008516932A (ja) | 2008-05-22 |
WO2006040465A3 (fr) | 2006-08-10 |
NO20072192L (no) | 2007-04-27 |
EP1805167A2 (fr) | 2007-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL176547A0 (en) | 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity | |
WO2007119106A3 (en) | Processes for preparing intermediate compounds useful for the preparation of ezetimibe | |
TW200624421A (en) | Method for preparing n-phenylpyrazole-1-carboxamides | |
HK1089444A1 (en) | Dihydropteridinones, method for the production and use thereof in the form of drugs | |
TNSN06409A1 (en) | Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof | |
WO2007030721A3 (en) | Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe | |
TW200745039A (en) | Isotopically substituted pantoprazole | |
WO2003104473A3 (de) | Galactosyl-isomalt, verfahren zu seiner herstellung und verwendung | |
MXPA05012362A (es) | Yodopirazolilcarboxanilidas. | |
HK1159614A1 (en) | Caspase inhibitors and uses thereof | |
AP2005003220A0 (en) | Novel polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-Alpha]-Pyrimidin-7-YI}Phenyl) Acetanide and compositions and methods related thereto. | |
WO2008032338A3 (en) | Improved process for the preparation of ezetimibe and its intermediates | |
MX2007004483A (es) | Metodo y productos intermediarios para la preparacion de derivados de n-(1-benzhidril-azetidin-3-il)-n- fenilmetilsulfonamida. | |
MX2007003923A (es) | Nuevo producto, procedimiento e intermediarios de preparacion de derivados de azetidina. | |
TW200626555A (en) | A process for the preparation of 1, 3, 5-trisubstituted pyrazoles via [3+2] cycloaddition | |
AU2003235814A8 (en) | Novel process for the preparation of trans-3- ethyl-2,5- dihydro-4- methyl-n-(2-( 4-(((((4-methyl cyclohexyl) amino)carbonyl) amino)sulfonyl) phenyl)ethyl) -2-oxo-1h-pyrrole -1-carboxamide | |
MX2007007554A (es) | Oxiarenos sustituidos. | |
MXPA05004262A (es) | Proceso para elaborar compuestos de pirazol. | |
PL1660463T3 (pl) | Sposób wytwarzania pochodnych fenylotetrazolu | |
ATE442370T1 (de) | Fungizide 6-phenyl-pyrazolopyrimidin-7-ylamine | |
MXPA05009153A (es) | Proceso para preparar 2-metilpirrolidina y enantiomeros especificos de la misma. | |
TW200407314A (en) | Preparation of 4, 6-dichloro-5-fluoropyrimidine | |
UA84594C2 (en) | 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives as cb1 antagonists | |
WO2003080567A3 (en) | Intermediates for the synthesis of discodermolide and related analogues and methods for their preparation | |
SG145574A1 (en) | Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |